• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于中医的新药发现和开发在中国。

TCM-based new drug discovery and development in China.

机构信息

Shanghai Research Center for Modernization of Traditional Chinese Medicine and National Engineering Laboratory for TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

Shanghai Research Center for Modernization of Traditional Chinese Medicine and National Engineering Laboratory for TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

Chin J Nat Med. 2014 Apr;12(4):241-50. doi: 10.1016/S1875-5364(14)60050-9.

DOI:10.1016/S1875-5364(14)60050-9
PMID:24863348
Abstract

Over the past 30 years, China has significantly improved the drug development environment by establishing a series of policies for the regulation of new drug approval. The regulatory system for new drug evaluation and registration in China was gradually developed in accordance with international standards. The approval and registration of TCM in China became as strict as those of chemical drugs and biological products. In this review, TCM-based new drug discovery and development are introduced according to the TCM classification of nine categories.

摘要

在过去的 30 年中,中国通过建立一系列新药审批监管政策,极大地改善了药物开发环境。中国新药评价和注册监管体系逐步按照国际标准发展,中药的审批和注册与化学药品和生物制品一样严格。本文按照中药九类分类,介绍了基于中药的新药发现和开发。

相似文献

1
TCM-based new drug discovery and development in China.基于中医的新药发现和开发在中国。
Chin J Nat Med. 2014 Apr;12(4):241-50. doi: 10.1016/S1875-5364(14)60050-9.
2
[Significance of re-evaluation and development of Chinese herbal drugs].[中药再评价与开发的意义]
Zhongguo Zhong Yao Za Zhi. 2012 Jan;37(1):1-4.
3
[Study on registration administration of extracts of traditional Chinese medicine and its preparation].中药提取物及其制剂注册管理研究
Zhongguo Zhong Yao Za Zhi. 2013 May;38(10):1627-30.
4
[Theory of toxic classification of traditional Chinese medicine and recommendations for revision of China pharmacopeia (volume 1)].[中药毒性分类理论及《中国药典》(一部)修订建议]
Zhongguo Zhong Yao Za Zhi. 2012 Aug;37(15):2193-8.
5
Future development of global regulations of Chinese herbal products.中草药全球监管法规的未来发展。
J Ethnopharmacol. 2012 Apr 10;140(3):568-86. doi: 10.1016/j.jep.2012.02.029. Epub 2012 Feb 25.
6
[Problems in medicinal materials research of new traditional Chinese medicine].[新中药的药材研究中的问题]
Zhongguo Zhong Yao Za Zhi. 2014 Aug;39(16):3192-5.
7
Tailored to fit: China optimizes policies and regulations regarding drug registration and review to promote innovation in traditional Chinese medicine.量体裁衣:中国优化药品注册审评制度,促进中药创新发展。
Drug Discov Ther. 2024 Sep 19;18(4):210-212. doi: 10.5582/ddt.2024.01055. Epub 2024 Jul 20.
8
[Discovery, research and development for innovative drug of traditional Chinese medicine under new situations].新形势下中药创新药物的发现、研究与开发
Zhongguo Zhong Yao Za Zhi. 2015 Sep;40(17):3423-8.
9
[Analysis on reasons for disapproval of registration application of new traditional Chinese medicines in recent years].[近年来中药新药注册申请不批准原因分析]
Zhongguo Zhong Yao Za Zhi. 2012 Aug;37(15):2333-7.
10
[Application of traditional Chinese medicine reference standards in quality control of Chinese herbal pieces].[中药对照标准在中药饮片质量控制中的应用]
Zhongguo Zhong Yao Za Zhi. 2014 Jan;39(1):149-52.

引用本文的文献

1
Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA.苦瓜MAP30对CENPA介导的膀胱癌细胞衰老、增殖和迁移的抑制作用
Sci Rep. 2025 Aug 13;15(1):29679. doi: 10.1038/s41598-025-14977-y.
2
Quantitative analysis of new drug registration policies for traditional Chinese medicine using the PMC index model.运用PMC指数模型对中药新药注册政策进行定量分析。
Front Public Health. 2025 May 27;13:1585350. doi: 10.3389/fpubh.2025.1585350. eCollection 2025.
3
Brain-Targeting Emodin Mitigates Ischemic Stroke via Inhibiting AQP4-Mediated Swelling and Neuroinflammation.
脑靶向大黄素通过抑制水通道蛋白4介导的肿胀和神经炎症减轻缺血性中风
Transl Stroke Res. 2024 Aug;15(4):818-830. doi: 10.1007/s12975-023-01170-4. Epub 2023 Jun 28.
4
Mass spectrometry imaging: new eyes on natural products for drug research and development.质谱成像:新药研发中天然产物的新视角。
Acta Pharmacol Sin. 2022 Dec;43(12):3096-3111. doi: 10.1038/s41401-022-00990-8. Epub 2022 Oct 13.
5
Asafoetida exerts neuroprotective effect on oxidative stress induced apoptosis through PI3K/Akt/GSK3β/Nrf2/HO-1 pathway.阿魏通过PI3K/Akt/GSK3β/Nrf2/HO-1信号通路对氧化应激诱导的细胞凋亡发挥神经保护作用。
Chin Med. 2022 Jul 6;17(1):83. doi: 10.1186/s13020-022-00630-7.
6
An alcohol extract prepared from the male flower of Eucommia ulmoides Oliv. promotes synoviocyte apoptosis and ameliorates bone destruction in rheumatoid arthritis.杜仲雄花制备的醇提取物可促进滑膜细胞凋亡并改善类风湿性关节炎中的骨质破坏。
Chin Med. 2021 Nov 6;16(1):113. doi: 10.1186/s13020-021-00522-2.
7
Antiepileptic Effects of Cicadae Periostracum on Mice and Its Antiapoptotic Effects in HO-Stimulated PC12 Cells via Regulation of PI3K/Akt/Nrf2 Signaling Pathways.蝉蜕对小鼠的抗癫痫作用及其通过调节 PI3K/Akt/Nrf2 信号通路对 HO 刺激 PC12 细胞的抗凋亡作用。
Oxid Med Cell Longev. 2021 Jul 20;2021:5598818. doi: 10.1155/2021/5598818. eCollection 2021.
8
Qihu Preparation Ameliorates Diabetes by Activating the AMPK Signaling Pathway in db/db Mice.芪虎制剂通过激活db/db小鼠的AMPK信号通路改善糖尿病。
Diabetes Metab Syndr Obes. 2021 Jul 14;14:3229-3241. doi: 10.2147/DMSO.S312137. eCollection 2021.
9
Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs.当代药物研发中的生物碱以满足全球疾病需求。
Molecules. 2021 Jun 22;26(13):3800. doi: 10.3390/molecules26133800.
10
Antistress Effects of Decoction on Restraint-Stressed Mice Revealed by H NMR-Based Metabolomics and Biochemistry Analysis.基于核磁共振代谢组学和生物化学分析揭示复方对束缚应激小鼠的抗应激作用。
Oxid Med Cell Longev. 2019 Apr 16;2019:5897675. doi: 10.1155/2019/5897675. eCollection 2019.